Posted On: 11/23/2015 5:40:21 PM
Post# of 30015
As of November 20, 2015, there were 13,499,000 shares of common stock outstanding.
During the Nine months ended September 30, 2015 and 2014, we generated no revenue. No revenue from Lympro.
During the Nine months ended September 30, 2015 and 2014, we generated no revenue. No revenue from Lympro.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)